Pfizer donates $70 mn worth COVID-19 treatment drugs to India

“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” says Pfizer Chairman and CEO Albert Bourla

May 03, 2021 12:53 pm | Updated 12:53 pm IST - New Delhi

File photo of Pfizer company logo at the company’s headquarters in New York.

File photo of Pfizer company logo at the company’s headquarters in New York.

Global pharma major Pfizer is sending its medicines worth $70 million (over ₹510 crore), from its distribution centres in the U.S., Europe and Asia, that have been identified as part of India’s COVID-19 treatment protocol, the company’s Chairman and CEO Albert Bourla said on May 3.

“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” he said in a mail sent to Pfizer India employees that he has shared on his linked.in post.

“We are committed to being a partner in India’s fight against this disease and are quickly working to mobilise the largest humanitarian relief effort in our company’s history,” Mr. Bourla said.

Right now, Pfizer colleagues at distribution centres in the U.S., Europe and Asia are hard at work rushing shipments of Pfizer medicines that the Government of India has identified as part of its COVID-19 treatment protocol, he added.

“We are donating these medicines to help make sure that every COVID-19 patient in every public hospital across the country can have access to the Pfizer medicines they need free of charge,” Mr. Bourla said.

These medicines, valued at more than $70 million, will be made available immediately, and “we will work closely with the government and our NGO partners to get them to where they are needed most,” he added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.